saundra buys banner

Publications

adobe

Breast-Cancer Risk in Families with Mutations in PALB2.
A.C. Antoniou, S. Casadei, T. Heikkinen, D. Barrowdale, K. Pylkäs, J. Roberts, A. Lee, D. Subramanian, K. De Leeneer, F. Fostira, E. Tomiak, S.L. Neuhausen, Z.L. Teo, S. Khan, K. Aittomäki, J.S. Moilanen, C. Turnbull, S. Seal, A. Mannermaa, A. Kallioniemi, G.J. Lindeman, S.S. Buys, I.L. Andrulis, P. Radice, C. Tondini, S. Manoukian, A.E. Toland, P. Miron, J.N. Weitzel, S.M. Domchek, B. Poppe, K.B.M. Claes, D. Yannoukakos, P. Concannon, J.L. Bernstein, P.A. James, D.F. Easton, D.E. Goldgar, J.L. Hopper, N. Rahman, P. Peterlongo, H. Nevanlinna, M.-C. King, F.J. Couch, M.C. Southey, R. Winqvist, W.D. Foulkes, and M. Tischkowitz.
N Engl J Med. 2014 371(6), 497-506.

adobe

Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry.
Ferris JS, Daly MB, Buys SS, Genkinger JM, Liao Y, Terry MB.
Br J Cancer, 2014 110(4),1074-80.

adobe

Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.
John EM, McGuire V, Thomas D, Haile R, Ozcelik H, Milne RL, Felberg A, West DW, Miron A, Knight JA, Terry MB, Daly M, Buys SS, Andrulis IL, Hopper JL, Southey MC, Giles GG, Apicella C, Thorne H, Whittemore AS.
Cancer Epidemiol Biomarkers Prev. 2013 22(9),1547-56.

adobe

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Nogues C, Stoppa-Lyonnet D, Bonadona V, Pujol P, McLachlan SA, John EM, Hooning MJ, Seynaeve C, Tollenaar RA, Goldgar DE, Terry MB, Caldes T, Weideman PC, Andrulis IL, Singer CF, Birch K, Simard J, Southey MC, Olsson HL, Jakubowska A, Olah E, Gerdes AM, Foretova L, Hopper JL.
J Clin Oncol. 2013 31(25), 3091-9

adobe

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD. 
Int J Cancer. 2013 132(9), 2127-33.

adobe

Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
Mocci E, Milne RL, Mendez-Villamil EY, Hopper JL, John EM, Andrulis IL, Chung WK, Daly M, Buys SS, Malats N, Goldgar DE.
Cancer Epidemiol Biomarkers Prev. 2013 22(5), 803-11.

adobe

Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry.
Zhang FF, John EM, Knight JA, Kaur M, Daly M, Buys S, Andrulis IL, Stearman B, West D, Terry MB. 
Breast Cancer Res Treat. 2013 137(2), 541-51.

adobe

Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy.
Schoen RD, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, PLCO Project Team.
N Engl J Med. 2012 366(25), 2345-57.

adobe

Effects of BRCA1 and BRCA2 mutations on female fertility.
Smith KR, Hanson HA, Mineau GP, Buys SS.
Proc Biol Sci. 2012 279(1732), 1389-95.

adobe

Rare mutations in XRCC2 increase the risk of breast cancer.
Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC.
Am J Hum Genet. 2012 90(4), 734-9.

adobe

Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.
Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS.  
Gynecol Oncol. 2012 125(1), 70-4.

adobe

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD.
JAMA. 2011 305(22), 2295-303.

adobe

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Maehle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramon Y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E, Moss S, Eeles RA.
Eur Urol. 2014 Jan 15 pii: S0302-2838(14)00004-9.